Regarding the skeletal muscle, there is growing evidence that SMN depletion leads to aberrant muscle and NMJ development in SMA mice [109–113] and aberrant muscle structure and function in human SMA patients have been confirmed (see chapter on electrophysiological biomarkers and [103, 108, 114–116]). Here, SMN2 is linked to proximal spinal muscular atrophy.